Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 391 | 734 | N/A | N/A |
| Receivables | 127 | 176 | N/A | N/A |
| TOTAL | $532 | $933 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 7 | 10 | N/A | N/A |
| TOTAL | $7 | $10 | $N/A | $N/A |
| Total Assets | $540 | $943 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 4,050 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 252 | 248 | 0 | 0 |
| Accrued Expenses | 343 | 242 | N/A | N/A |
| Other current liabilities | 575 | N/A | N/A | N/A |
| TOTAL | $5,270 | $4,589 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,270 | $4,589 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -5,372 | -4,224 | N/A | N/A |
| Other shareholders' equity | 132 | 68 | 0 | 0 |
| TOTAL | $-4,731 | $-3,646 | $N/A | $N/A |
| Total Liabilities And Equity | $540 | $943 | $0 | $0 |